Previous 10 | Next 10 |
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 2, 2021 on Wednesday, May 5, 2021 ...
STAAR Surgical (NASDAQ: STAA) has been a top-performing healthcare stock over the past year, with a mouth-watering return of 244%, compared to a 48% rise in the S&P 500 over the same period. Right now, STAAR Surgical is prohibitively expensive at 33 tim...
Shares of STAAR Surgical Company (NASDAQ: STAA) are rising sharply on Tuesday, up by 10.8% as of 12:42 p.m. EST, after jumping by as much as 13.8% earlier in the day. However, there doesn't seem to be any company-specific catalysts for these gains. The implantable lenses manufacture...
Staar Surgical manufactures and markets implantable collamer lenses for myopia or presbyopia. The company's shares have performed impressively in recent months - reaching highs of $127 - but have fallen to $104 during the recent bear market. Based on DCF analysis, Staar looks over...
Image source: The Motley Fool. Staar Surgical Co (NASDAQ: STAA) Q4 2020 Earnings Call Feb 24, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Staar Surgical Co (STAA) Q4 2020 Earnings Call Transcript
STAAR Surgical Company (STAA) Q4 2020 Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants Brian Moore - VP, Investor, Media Relations and Corporate Development Caren Mason - President and CEO Patrick Williams - Chief Financial Officer Conference Call Participants Chris ...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended January 1, 2021. Fourth Quarter 2020 Overview ...
[[ACA]], [[ACAD]], [[ADPT]], [[AGI]], [[AMED]], [[ANSS]], [[APA]], [[AWK]], [[BILI]], [[BKNG]], [[CCRN]], [[CDNA]], [[CHDN]], [[CNXN]], [[CW]], [[DDD]], [[DOOR]], [[DRH]], [[ECPG]], [[EPR]], [[ESI]], [[ESTC]], [[FATE]], [[FNF]], [[FTI]], [[GBT]], [[GEF]], [[GH]], [[HCC]], [[ICLR]], [[INGN]], ...
Shares of implantable lenses manufacturer STAAR Surgical Company (NASDAQ: STAA) are falling sharply on Tuesday and were down by 4.9% as of 2:08 p.m. EST, after dropping by as much as 12.3% earlier in the day. The company did not report any news, but the most likely reason it is losi...
Healthcare lagged the broader market last year, but that can change this year. A cyclical upturn as the pandemic abates and pent-up demand can boost healthcare. Best positioned are industry groups within healthcare that can achieve secular growth beyond the cyclical rise. Biot...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...